__PRESENT__PRESENT
__PRESENT__PRESENT__PRESENT
__PRESENT
__PRESENT
__PRESENT
Enter your details to join our mobile app waitlist and receive early access to the Bell Direct App.
Latest stock market podcasts
From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
- (0:56) A brief overview of Starpharma
- (2:31) Growing distribution network for Viraleze
- (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
- (4:56) How Viraleze works and the market opportunity going forward
- (6:09) What’s coming up next for SPL
WeMoney 2025
Best for Market Research Insights
Best for Market Research Insights
Highest Overall
Client Satisfaction
2013-2023
Client Satisfaction
2013-2023
Finder 2022
Most Loved
Share Trading Platform
Most Loved
Share Trading Platform
Number one spot for ‘Legendary Service’ scoring 4.31/5 with high marks for customer service trustworthiness.